TNSN08016A1 - Complexes containing perfluoroalkyl, method for the production and use thereof - Google Patents

Complexes containing perfluoroalkyl, method for the production and use thereof

Info

Publication number
TNSN08016A1
TNSN08016A1 TNP2008000016A TNSN08016A TNSN08016A1 TN SN08016 A1 TNSN08016 A1 TN SN08016A1 TN P2008000016 A TNP2008000016 A TN P2008000016A TN SN08016 A TNSN08016 A TN SN08016A TN SN08016 A1 TNSN08016 A1 TN SN08016A1
Authority
TN
Tunisia
Prior art keywords
production
complexes containing
containing perfluoroalkyl
field
perfluoroalky
Prior art date
Application number
TNP2008000016A
Other languages
English (en)
Inventor
Heiko Schirmer
Hanns-Joachim Weinmann
Johannes Platzek
Ludwig Zorn
Bernd Misselwitz
Jörg Meding
Heribert Schmitt-Willich
Brumby Thomas (De)
Original Assignee
Bayer Schering Pharma Ag
Epix Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag, Epix Pharmaceuticals filed Critical Bayer Schering Pharma Ag
Publication of TNSN08016A1 publication Critical patent/TNSN08016A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TNP2008000016A 2005-07-15 2008-01-14 Complexes containing perfluoroalkyl, method for the production and use thereof TNSN08016A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005033902A DE102005033902B3 (de) 2005-07-15 2005-07-15 Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel
PCT/EP2006/006777 WO2007009638A2 (de) 2005-07-15 2006-07-11 Perfluoralkylhaltige komplexe, verfahren zu deren herstellung sowie deren verwendung

Publications (1)

Publication Number Publication Date
TNSN08016A1 true TNSN08016A1 (en) 2009-07-14

Family

ID=37057146

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2008000016A TNSN08016A1 (en) 2005-07-15 2008-01-14 Complexes containing perfluoroalkyl, method for the production and use thereof

Country Status (22)

Country Link
EP (1) EP1904463A2 (es)
JP (1) JP2009501174A (es)
KR (1) KR20080043762A (es)
CN (1) CN101223148A (es)
AR (1) AR054865A1 (es)
AU (1) AU2006272025A1 (es)
BR (1) BRPI0613407A2 (es)
CA (1) CA2615443A1 (es)
CR (1) CR9645A (es)
DE (1) DE102005033902B3 (es)
DO (1) DOP2006000167A (es)
EC (1) ECSP088100A (es)
GT (1) GT200600313A (es)
IL (1) IL187926A0 (es)
NO (1) NO20080813L (es)
PE (1) PE20070376A1 (es)
RU (1) RU2008105356A (es)
TN (1) TNSN08016A1 (es)
TW (1) TW200706538A (es)
UY (1) UY29664A1 (es)
WO (1) WO2007009638A2 (es)
ZA (1) ZA200801523B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007015598A1 (de) * 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Verwendung von fluorhaltigen Verbindungen zu Diagnosezwecken mit Hilfe bildgebender Verfahren
KR101861025B1 (ko) 2008-01-08 2018-05-24 랜티우스 메디컬 이메징, 인크. 영상화 제제로서의 ｎ-알콕시아미드 접합체
EP4037691A4 (en) * 2019-10-04 2023-11-22 United States Government as Represented by The Department of Veterans Affairs IMAGING DEVELOPMENT AND THERAPEUTIC GLUCOSE ANALOGS OF SODIUM-DEPENDENT GLUCOSE TRANSPORTERS
EP4059925A1 (en) 2021-03-15 2022-09-21 Bayer Aktiengesellschaft New contrast agent for use in magnetic resonance imaging
CN114181164A (zh) * 2021-12-13 2022-03-15 武汉大学中南医院 基于Fe(Ⅱ)特异性MRI对比剂的合成方法及其应用
EP4335840A1 (en) 2022-09-09 2024-03-13 Bayer Aktiengesellschaft New contrast agents for use in diagnostic imaging
EP4335462A1 (en) 2022-09-09 2024-03-13 Bayer AG Contrast agents for use in diagnostic computed tomography imaging

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317588C2 (de) * 1993-05-24 1998-04-16 Schering Ag Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744003B4 (de) * 1997-09-26 2004-07-08 Schering Ag Kontrastmittel für das Infarkt- und Nekroseimaging
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
DE10040858C2 (de) * 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
WO2007009638A3 (de) 2007-04-26
WO2007009638A2 (de) 2007-01-25
AR054865A1 (es) 2007-07-25
AU2006272025A1 (en) 2007-01-25
GT200600313A (es) 2007-04-23
IL187926A0 (en) 2008-03-20
ZA200801523B (en) 2008-11-26
UY29664A1 (es) 2007-02-28
KR20080043762A (ko) 2008-05-19
EP1904463A2 (de) 2008-04-02
JP2009501174A (ja) 2009-01-15
DE102005033902B3 (de) 2007-04-05
PE20070376A1 (es) 2007-04-20
CA2615443A1 (en) 2007-01-25
CN101223148A (zh) 2008-07-16
RU2008105356A (ru) 2009-08-20
CR9645A (es) 2008-05-21
DOP2006000167A (es) 2007-02-28
NO20080813L (no) 2008-04-09
TW200706538A (en) 2007-02-16
ECSP088100A (es) 2008-05-30
BRPI0613407A2 (pt) 2011-01-11

Similar Documents

Publication Publication Date Title
TNSN08016A1 (en) Complexes containing perfluoroalkyl, method for the production and use thereof
WO2007009637A3 (de) Deren verwendung als kontrastmittel zur anwendung in der nmr-, rontgen- und radiodiagnostik sowie in der radiotheraphie
WO2007002109A3 (en) Multidentate pyrone-derived chelators for medicinal imaging and chelation
MX2023010737A (es) Nuevo agente de contraste para utilizar en imagenes por resonancia magnetica.
PH12017502205A1 (en) New gadolinium chelate compounds for use in magnetic resonance imaging
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
MX2020010639A (es) Anticuerpos humanizados a liv-1 y uso de los mismos para tratar cancer.
MX2007001035A (es) Metodo para producir una composicion, la composicion y su uso.
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
MY153198A (en) Inhibitors of protein aggregation
DE502006007526D1 (de) Antimikrobielles medizintechnisches produkt, verfahren zu seiner herstellung und verwendung
WO2013188417A3 (en) Treatment and prevention of cardiovascular disease and thrombosis
MX2007006355A (es) Epitopes antigenos de interleucina-21, anticuerpos relacionados y su uso en el campo medico.
ATE361299T1 (de) Oligomere der gadolinium chelate, ihre verwendung als nmr-kontrastmittel und zwischenverbindungen
EA201170344A1 (ru) Азаиндольные ингибиторы iap
NO20091495L (no) Pyrazolopyrimidinderivat
MX2010000956A (es) Derivados de isoftalamida que inhiben actividad de beta-secretasa.
WO2005030794A3 (en) Hemiasterlin derivatives and uses thereof
MY148553A (en) Metal chelates having a perfluorinated peg radical, processes for their preparation, and their use
ATE486284T1 (de) Detektion, überwachung und behandlung von krebs
TW200744647A (en) Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents
MX2022002586A (es) Isomeros de quelatos de manganeso.
WO2007121312A3 (en) Trivalent chromium compounds, compositions and methods of use
JOP20210162A1 (ar) جسيم نانوي، وعامل تباين للتصوير بالرنين المغناطيسي يشتمل على الجسيم النانوي، ومركب ترابطي ثنائي القطب
WO2008025941A3 (en) Compounds for imaging and therapy